Delivery Order SPE2DR25D1017-SPE2DR26F9CSR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). This is a non-set-aside competitive award with an ultimate completion date of January 8, 2026, and performance location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10 on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,991.36 to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit-dose packages of 10, with an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,081.00 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,684.75 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This competitively awarded, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CSRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,690.92 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (Unit Dose, 10-count) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a comprehensive range of medical products to federal agencies, particularly the Defense Logistics Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, reflects the contractor's ongoing role in meeting Department of Defense pharmaceutical supply requirements through the DLA Troop Support Medical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/6/26 |